SCREENING FOR EARLY LUNG CANCER. Pang Yong Kek
|
|
- Imogen Perry
- 5 years ago
- Views:
Transcription
1 SCREENING FOR EARLY LUNG CANCER Pang Yong Kek
2 Lecture Outline Why performing screening? How to improve early detection? Benefits and Risks of screening Challenges in screening Conclusion
3 Why Performing Screening? Lung cancer is one of the commonest cancer afflicting mankind Vast majority of the victims have advanced disease at the time of presentation Despite the significant improvement made in treatment modality, mortality of lung cancer remains high In 2018, it is estimated that 154,050 deaths from lung cancer will occur in the United States. Five-year survival rates for lung cancer are only 18%
4 Lung cancer In Malaysia, lung cancer accounts for 13.8% of all cancers in males and 3.8% of all cancers in females Second Report of the National Cancer Registry. Cancer incidence in Malaysia, National Cancer Registry, Malaysia (
5 Clinical stage of NSCLC at diagnosis - UMMC Stage 3b & 4 = 69% (37%) n = 580 (32%) No of patients Stage 3a, 7% Stage of disease 76% of patients with NSCLC present with stage III or stage IV disease 1. Liam CK et al. Respirology 2000; 5:355-61; 2. Liam CK et al. Chest 2002; 121:309-10
6 Why Performing Screening? Screening often leads to detection of early stage disease Early stage disease = Higher chance curative treatment = Better Life Expectancy + Improved Quality of Life
7 How To Screen? Most of the early lung cancer does not have any sign or symptom, Imaging of the chest has been regarded as a potentially useful tool to identify the nodule in the lung Historical study: CXR & sputum cytology versus standard of care has failed to demonstrate survival benefit in high risk individuals 1. Moyer VA, Force USPST. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160: Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143:e78S 92S.
8 How To Screen? In recent years, due to advances made in imaging technology, the idea has been re-investigated using low-dose CT scan (LDCT) Source: The Valley Health Cancer Center website
9 NLST Study The National Lung Screening Trial (NLST) is a trial conducted on over 53,000 high-risk individuals in the US. They are defined as Aged years Current smokers or Ex-smokers (who had quit 15 years) 30 pack-years
10 NLST Study Subjects were randomised for screening with LDCT Thorax versus Chest X-ray Each subject will get 3 scans (baseline and annually for 2 years) After that they were followed up for another 3.5 years Result: the LDCT arm showed a 20% (95% CI, ; P=.004) reduction in mortality from lung cancer compared to the CXR
11 Tobacco and Risk of Lung Cancer The overall relative risk (RR) for lung cancer is 20-fold higher for smokers than for non-smokers. In general, the more tobacco is smoked, the higher is the risk Cessation of tobacco smoking decreases the risk for lung cancer.
12 Other Risk Factors of Lung Cancer Although smoking tobacco is a well-established risk factor for lung cancer, other environmental and genetic factors also increase the risk These include: Occupational exposure History of lung or other cancers Family history of cancer
13 Other Risk Factors - Occupational exposure Carcinogens targeting the lungs include arsenic, chromium, asbestos, nickel, cadmium, beryllium, silica, diesel fumes, coal smoke, and soot. Radon exposure
14 Other Risk Factors Previous cancer Patients with other cancers are also at increased risk of cancer, e.g. : Survivors of primary lung cancer, lymphomas, cancers of the head and neck, or smoking-related cancers, such as bladder cancer. Patients previously treated with chest irradiation have a 13-fold increased risk of developing a new primary lung cancer, Those who have previously been treated with alkylating agents (chemotherapy) have an estimated RR of 9.4
15 Other Risk Factors - Family history of cancer Several studies have shown the 1st degree relatives of a lung cancer patient are at increased risk of lung cancer A meta-analysis of 28 case-control studies and 17 observational cohort studies showed an RR of 1.8 (95% CI, ) for individuals with a sibling/parents or a first-degree relative with lung cancer The risk is greater in individuals with multiple affected family members or who had a cancer diagnosis at a young age.
16 Selection of individuals for Screening The NCCN Panel recommends that only those with high risk should be screened Those with moderate or low risk should not be screened In addition, only those who are the potential candidates for curative therapy should be screened.
17 High Risk Patients Group 1: Individuals aged 55 to 74 years with a 30 pack-year history of smoking tobacco who currently smoke or, if former smoker, have quit within 15 years (category 1). Group 2 Individuals aged 50 years or older with a 20 pack-year history of smoking tobacco and with one additional risk factor (category 2A). (Screening beyond the NLST criteria)
18 High Risk Patients For Group 2, screening may be offered if they have one of the additional risk factors below: personal history of cancer or lung disease, family history of lung cancer, radon exposure, occupational exposure to carcinogens.
19 Benefits Detection of early disease when it is still curable Although patients with earliest-stage disease (IA) may have a 5-year survival rate of 75% with surgery, the outcomes quickly decrease with increasing stages In the NLST, 356 participants died of lung cancer in the LDCT arm and 443 participants died of lung cancer in the chest radiograph arm. To prevent 1 death from lung cancer, 320 individuals with high-risk factors must be screened with LDCT.
20 Benefits Improved survival
21 Benefits Improved quality of life as a result of Early disease detection and curative treatment The NLST found that 40% of the cancers detected in the CT-screening group were stage IA, 12% were stage IIIB, and 22% were stage IV. Conversely, 21% of the cancers detected in the CXR group were stage IA, 13% were stage IIIB, and 36% were stage IV. These results suggest that LDCT screening decreases the number of cases of advanced National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:
22 Benefits Identification of other treatable disease, e.g. COPD, coronary artery disease National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:
23 Benefits Long-term cost may be reduced Upfront costs, e.g. screening, additional diagnostic procedures and other interventions will increase; however Future costs of treating advanced diseases with chemotherapy, targetable agents, immunotherapy, radiation therapy and others will be reduced
24 Benefits Provide an opportunity to persuade chronic smokers to stop smoking
25 Risks/Harms Screening leads to identification of many false positive nodules, which result in many unnecessary interventions In the NLST, the false-positive rate was 96.4% for the CT screening group. This is reduced to 33% with 2 annual sequential LDCT. Those who were screened positive may require interval imaging, percutaneous needle biopsy, or even surgical biopsy
26 Risks/Harms Some of these procedures are not without any risk the average surgical mortality rate for major lung surgery across the US is 5%, and the frequency of serious complications is > 20%.
27 Risks/Harms False-negative results may delay or prevent diagnosis and treatment because of a false sense of good health
28 Risks/Harms Futile detection of small aggressive tumour Futile detection of indolent disease (over-diagnosis)
29 Risks/Harms Identification of any nodule will lead to anxiety for the screened subjects False-positive and indeterminate results may decrease quality of life because of mental anguish and additional testing
30 Risks/Harms Risk of radiation Using low-dose techniques, the mean effective radiation dose is 1.5 msv (SD ± 0.5 msv) compared with an average of 7 msv for conventional CT scan The radiation dose of LDCT is 10 X that of CXR Brenner et al estimated a 1.8% increase in lung cancer cases if 50% of all current and former smokers in the US between 50 and 75 years of age were to undergo annual screening LDCT.
31 Cost-effectiveness The cost-effectiveness of LCS is also important to consider. LDCT imaging is more expensive than many other screening programs, and therefore it is important to validate the effectiveness of screening. 7 analyses have reported a cost effectiveness ratio of $100,000 (in U.S. dollars) or less per quality adjusted life years gained for LDCT. A threshold level of $100,000 per quality-adjusted life year gained is what some experts consider to be a reasonable value in the United States
32 Other Challenges Screening of early cancer is not a substitute for effort to promote smoking cessation In fact, it should be used an opportunity to pursuit subject to quit smoking (if they are still smoking)
33 Other Challenges Early lung cancer screening has not been prospectively tested in this country Lack of resources (time for counselling, CT machine and interventionists) Many high risk individuals are non-smoker, and younger than those traditionally included in the trial (< years old) TB is common in this part of the world and this may result in a lot of false positive cases
34 Future opportunity Can we increase to sensitivity and specificity of the screening test? Combination with sputum test or breath test Combination with blood test
35 Future opportunity Can we increase to sensitivity and specificity of the screening test? PET-CT scan? PET-CT has been shown to increase the specificity for malignancy (7 10mm) PET has low sensitivity for nodules with < 8 mm of solid component and for small nodules near the diaphragm.
36 Conclusion Recent NLST has shown positive result for early lung cancer screening by employing LDCT. However, 3 other trials: MILD (Multicentre Italian Lung Detection), DANTE (Detection And screening of early lung cancer with Novel imaging TEchnology), Danish Lung Cancer Screening Trial (all using the LDCT) did not show a positive outcome in term of mortality Before such screening is being performed here, every aspect of the programme should be explored and deliberated.
37
Screening for Lung Cancer: New Guidelines, Old Problems
Screening for Lung Cancer: New Guidelines, Old Problems Robert Schilz DO, PhD Associate Professor of Medicine Interim Chief of the Division of Pulmonary, Critical Care and Sleep Medicine University Hospitals
More informationLUNG CANCER SCREENING
LUNG CANCER SCREENING Christopher Lettieri MD, FACP, FCCP, FAASM Pulmonary/Critical Care Consultant to the Surgeon General Professor of Medicine Walter Reed National Military Medical Center American College
More informationMEDICAL POLICY SUBJECT: LOW-DOSE COMPUTED TOMOGRAPHY (LDCT) FOR LUNG CANCER SCREENING. POLICY NUMBER: CATEGORY: Technology Assessment
MEDICAL POLICY SUBJECT: LOW-DOSE COMPUTED CANCER SCREENING 05/18/05, 03/16/06, 12/21/06, 08/16/07, PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria
More informationLung Cancer Screening: To screen or not to screen?
Lung Cancer Screening: To screen or not to screen? Dan J. Raz, M.D. Co Director, Lung Cancer Screening Program Co Director, LungCancer and Thoracic OncologyProgram Assistant Professor, Thoracic Surgery
More informationLUNG CANCER SCREENING: LUNG CANCER SCREENING: THE TIME HAS COME LUNG CANCER: A NATIONAL EPIDEMIC
: THE TIME HAS COME Physician Leader, Lung Cancer Multi-Disciplinary Program Fletcher Allen Health Care Annual Meeting Montpelier, VT - April 25, 2014 Gerald S. Davis, MD Professor of Medicine University
More informationGoals of Presentation
Goals of Presentation Review context of lung cancer screening why is it important? Review data from NLST supporting screening with lowdose CT (LDCT) scanning Discuss the pros and cons of LDCT screening
More informationCLINICAL GUIDELINES. Lung-Cancer Screening Program Guidelines Robert Y. Kanterman, M.D. and Thomas J. Gilbert, M.D., M.P.P.
CLINICAL GUIDELINES Lung-Cancer Screening Program Guidelines Robert Y. Kanterman, M.D. and Thomas J. Gilbert, M.D., M.P.P. 3/14/2015 Introduction: The purpose of a lung-cancer screening program is to detect
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More informationCT Screening for Lung Cancer for High Risk Patients
CT Screening for Lung Cancer for High Risk Patients The recently published National Lung Cancer Screening Trial (NLST) showed that low-dose CT screening for lung cancer reduces mortality in high-risk patients
More informationLung Cancer Screening
Scan for mobile link. Lung Cancer Screening What is lung cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease at
More informationScreening for Lung Cancer - State of the Art
Screening for Lung Cancer - State of the Art Rohit Kumar, MD Assistant Professor of Medicine Fox Chase Cancer Center Temple University School of Medicine Philadelphia, PA Objectives Review current evidence
More informationCigna Medical Coverage Policy
Cigna Medical Coverage Policy Subject Low-Dose Computed Tomography for Lung Cancer Screening Effective Date... 2/15/2014 Next Review Date... 2/15/2015 Coverage Policy Number... 0007 Table of Contents Coverage
More informationLung Cancer Screening: To Screen or Not to Screen?
Lung Cancer Screening: To Screen or Not to Screen? Lorriana Leard, MD Co-Director of UCSF Lung Cancer Screening Program Vice Chief of Clinical Activities UCSF Pulmonary, Critical Care, Allergy & Sleep
More informationLung Cancer Screening: Benefits and limitations to its Implementation
Lung Cancer Screening: Benefits and limitations to its Implementation Rolando Sanchez, MD Clinical Assistant Professor Pulmonary-Critical Care Medicine University of Iowa Lung cancer - Epidemiology Cancer
More informationLUNG CANCER SCREENING WHAT S THE IMPACT? Nitra Piyavisetpat, MD Department of Radiology Chulalongkorn University
LUNG CANCER SCREENING WHAT S THE IMPACT? Nitra Piyavisetpat, MD Department of Radiology Chulalongkorn University Objective LDCT lung cancer screening (LCS) Potential Benefits & Harms Recommendation of
More informationScreening Programs background and clinical implementation. Denise R. Aberle, MD Professor of Radiology and Engineering
Screening Programs background and clinical implementation Denise R. Aberle, MD Professor of Radiology and Engineering disclosures I have no disclosures. I have no conflicts of interest relevant to this
More informationChristine Argento, MD Interventional Pulmonology Emory University
Christine Argento, MD Interventional Pulmonology Emory University Outline Lung Cancer Statistics Prior Studies for Lung Cancer Screening NLST Studies Following NLST Future Directions Lung Cancer American
More informationA Comprehensive Cancer Center Designated by the National Cancer Institute
N C I C C C A Comprehensive Cancer Center Designated by the National Cancer Institute Screening and Early Detection of Lung Cancer: Ready for Practice? David S. Ettinger, MD, FACP, FCCP Alex Grass Professor
More informationNone
2014 None rosemary clooney Cancer is one of the most common diseases in the developed world: 1 in 4 deaths are due to cancer 1 in 17 deaths are due to lung cancer Lung cancer is the most common
More informationProfessor John K Field PhD, FRCPath University of Liverpool Cancer Research Centre, UK.
Professor John K Field PhD, FRCPath University of Liverpool Cancer Research Centre, UK. J.K.Field@liv.ac.uk 1.8 million new cases in 2012 Bender Nature Outlook 2014 Probability of survival: ALL participants
More informationCharles Mulligan, MD, FACS, FCCP 26 March 2015
Charles Mulligan, MD, FACS, FCCP 26 March 2015 Review lung cancer statistics Review the risk factors Discuss presentation and staging Discuss treatment options and outcomes Discuss the status of screening
More informationCT screening for lung cancer. Should it be done in the Indian context?
CT screening for lung cancer Should it be done in the Indian context? Wilson and Jungner screening criteria 1. The condition sought should be an important health problem. 2. There should be an accepted
More informationPulmonologist s Perspective
Low-dose CT for lung cancer screening Pulmonologist s Perspective Literature Review Kang-Yun Lee, MD PhD Department of Thoracic Medicine Taipei Medical University- Shuang Ho Hospital Taiwan Local vs. Advanced
More informationDisclosures. Overview. Selection the most accurate statement: Updates in Lung Cancer Screening 5/26/17. No Financial Disclosures
Updates in Lung Cancer Screening Disclosures No Financial Disclosures Neil Trivedi, MD Associate Professor of Clinical Medicine SF VAMC Pulmonary and Critical Care Director, Bronchoscopy & Interventional
More informationLung Cancer Screening
Lung Cancer Screening Steven Leh, MD, FCCP Diplomat of the American Association for Bronchology and Interventional Pulmonology Aurora Medical Group Pulmonary and Sleep Medicine February 10, 2018 Disclosures
More informationWhat to know and what to make of it
Lung Cancer Screening: What to know and what to make of it J. Matthew Reinersman, MD Assistant Professor of Surgery Division of Thoracic and Cardiovascular Surgery Department of Surgery University of Oklahoma
More informationLUNG CANCER: LDCT DISCLOSURES NONE. Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, /9/2018
LUNG CANCER: LDCT Erika Swanson, MD Radiation Oncologist Ascension Columbia-St. Mary s February 1, 2018 DISCLOSURES 2 NONE 1 OBJECTIVES 3 Rationale and evidence for LDCT for lung cancer screening Review
More informationExample of lung screening
Justification of the use of CT for individual health assessment of asymptomatic people How to obtain evidence for IHA - Example of lung screening Mathias Prokop, MD PhD Professor of Radiology Radboud University
More informationLearning Objectives. 1. Identify which patients meet criteria for annual lung cancer screening
Disclosure I, Taylor Rowlett, DO NOT have a financial interest /arrangement or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context
More informationLung Cancer Screening
Lung Cancer Screening Preston Wright, DO University of Kansas School of Medicine- Wichita Family Medicine Residency at Via Christi Hospitals 1 Objectives Identify patients who need screened for lung cancer
More informationLung Cancer screening :
Lung Cancer screening : Pro-Contra SAMO interdisciplinary workshop on chest tumors 27 and 28 january 2017 Prof L.P.Nicod Sevice de pneumologie CHUV-Lausanne -CH Lung Cancer How big is the problem? Epidemiology
More informationAdvancing Health Equity in Lung Cancer Outcomes
Advancing Health Equity in Lung Cancer Outcomes Edwin J Jackson Jr. DO Pulmonary and Critical Care Medicine Disclosures Funding: American Thoracic Society 2 1 Lecture Outline Cancer Disparities Smoking
More informationLung Cancer Diagnosis for Primary Care
Lung Cancer Diagnosis for Primary Care Daniel Nader, DO, FCCP Cancer Treatment Center of America Case 1 In which of the following situations would the U.S. Preventive Services Task Force (USPSTF) recommend
More informationDOH LUNG CANCER SCREENING SERVICE SPECIFICATIONS
DOH LUNG CANCER SCREENING SERVICE SPECIFICATIONS December 2018 Page 1 of 18 Document Title: Document Ref. Number: DOH Lung Cancer Screening Service Specifications PH/NCD/LCSC/SR/0.9 Version: 0.9 Approval
More informationNCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening
444 Original Research NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening Brady J. McKee, MD; Shawn Regis, PhD; Andrea K. Borondy-Kitts, MS, MPH; Jeffrey A. Hashim, MD; Robert J.
More informationEmerging Challenges in Primary Care: Lung Cancer Screening: Who, When, Why Or Why Not? Objectives. Faculty
Emerging Challenges in Primary Care: 2017 Lung Cancer Screening: Who, When, Why Or Why Not? Louis Kuritzky, MD Clinical Assistant Professor Emeritus Department of Community Health and Family Medicine University
More informationLung Cancer Screening. Eric S. Papierniak, DO NF/SG VHA UF Health
Lung Cancer Screening Eric S. Papierniak, DO NF/SG VHA UF Health Overview Background Supporting evidence Guidelines Practical considerations Patient selection What to do with abnormal results Billing/coding
More informationLung Cancer Screening Trials. Edward Harris Respiratory Research Fellow Sir Charles Gairdner Hospital
Lung Cancer Screening Trials Edward Harris Respiratory Research Fellow Sir Charles Gairdner Hospital Lung Cancer Screening in Australia Not Funded except as part of a clinical trial Rationale PLCO, ELCAP
More informationLung Cancer Screening Who, When, Why
Lung Cancer Screening Who, When, Why Louis Kuritzky, MD Clinical Assistant Professor Emeritus Department of Community Health and Family Medicine University of Florida, Gainesville (352) 377 3193 Phone/FAX
More informationLung Cancer Screening
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Lung Cancer Screening Version 1.2015 NCCN.org NCCN Guidelines for Patients available at www.nccn.org/patients Continue Version 1.2015, 07/21/14
More informationWELLNESS INITIATIVE NOW
WELLNESS INITIATIVE NOW To promote personal well-being, fitness and nutrition for all TDCJ employees. November 2008 Lung cancer is cancer that forms in tissues of the lung, usually in the cells lining
More informationGCE AS/A level 1661/01-A APPLIED SCIENCE UNIT 1
GCE AS/A level 1661/01-A APPLIED SCIENCE UNIT 1 S16-1661-01A Pre-release Article for Examination in May 2016 1661 01A001 CJ*(S16-1661-01A) 2 Information for Teachers The pre-release article is intended
More informationUniversity of Connecticut. University of Connecticut Graduate School
University of Connecticut OpenCommons@UConn Master's Theses University of Connecticut Graduate School 5-7-2016 A Retrospective Study Assessing the Predictive Performance of a Lung Cancer Screening Risk
More informationDiagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD. November 18, 2017
Diagnosis and Staging of Non-Small Cell Lung Cancer Carlos Eduardo Oliveira Baleeiro, MD November 18, 2017 Disclosures I do not have a financial interest/arrangement or affiliation with one or more organizations
More informationLung Cancer: Diagnosis, Staging and Treatment
PATIENT EDUCATION patienteducation.osumc.edu Lung Cancer: Diagnosis, Staging and Treatment Cancer starts in your cells. Cells are the building blocks of your tissues. Tissues make up the organs of your
More informationLung Cancer and CT Screening
Lung Cancer and CT Screening Samer Kanaan, MD February 17 th, 2012 Goals Understand the Societal impact of Lung Cancer Identify Risk Factors for Lung Cancer List Diagnostic Tests Available for Lung Cancer
More informationLUNG CANCER SCREENING Anthony C. Campagna, M.D.
LUNG CANCER SCREENING 2012 Anthony C. Campagna, M.D. Attending Physician, Pulmonary and Critical Care Medicine Lahey Clinic, Burlington, MA Assistant Clinical Professor of Medicine Harvard Medical School,
More informationLung Cancer Screening
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Lung Cancer Screening Version 1.2014 NCCN.org Continue Version 1.2014, 06/12/13 National Comprehensive Cancer Network, Inc. 2013, All rights
More informationLUNGS? YOU GET THESE YOUR GUIDE TO YEARLY LUNG CANCER SCREENING CHECKED REGULARLY. WHAT ABOUT YOUR. Think. Screen. Know.
YOU GET THESE CHECKED REGULARLY. WHAT ABOUT YOUR LUNGS? YOUR GUIDE TO YEARLY LUNG CANCER SCREENING WHAT YOU SHOULD KNOW BEFORE, DURING, AND AFTER Think. Screen. Know. Talk to your doctor. TABLE OF CONTENTS
More informationLung Cancer Screening Benefits, Risks & Challenges
Lung Cancer Screening Benefits, Risks & Challenges Polly Sather, APRN Yale Lung Screening and Nodule Program (Yale Lung SCAN) A Multidisciplinary Comprehensive Initiative Yale Cancer Center Thoracic Oncology
More informationLUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS?
LUNG CANCER SCREENING: ON WHOM DID YOU DO IT AND ON WHOM DO YOU RESPOND TO THE RESULTS? DAVID O. WILSON, MD, MHP DIRECTOR GEORGIA COOPER MEMORIAL LUNG CANCER RESEARCH REGISTRY UNIVERSITY OF PITTSBURGH
More informationScreening for Lung Cancer
Screening for Lung Cancer 15 ΜΑΡΤΙΟΥ 2014 Ioannis Gkiozos Pulmonologist Oncology Unit G P General & Chest Diseases Hospital Sotiria Despite advances in therapy, 5-year survival rates of Lung Cancer Remains
More informationCT Low Dose Lung Cancer Screening. Part I. Journey to LDCT LCS Program
CT Low Dose Lung Cancer Screening Part I Journey to LDCT LCS Program Paul Johnson, M.S., DABHP, DABR Cleveland Clinic September 26, 2015 Lung Caner is No. 1 In Cancer Related Death In The United States
More informationLung Cancer Screening Computed Tomography Screening in Pa6ents at Risk for Lung Cancer
Lung Cancer Screening Computed Tomography Screening in Pa6ents at Risk for Lung Cancer Doug Arenberg, M.D. University of Michigan Disclosures Objec6ve Define patients who will benefit from screening for
More informationRole of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D.
Role of CT in Lung Cancer Screening: 2010 Stuart S. Sagel, M.D. Lung Cancer 219,440 new cases/year in U.S. (2009) 169,390 deaths/year in U.S. mortality greater than from breast, colon, prostate CA combined
More informationLung Cancer Screening In High Risk Populations:
Lung Cancer Screening In High Risk Populations: Michael Jaklitsch, M.D. Co-Chair of AATS Task Force on Lung Cancer Screening and Surveillance From the Brigham and Women s Hospital Harvard Medical School.
More informationNational Lung Screening Trial Results
National Lung Screening Trial Results Ella A. Kazerooni, M.D. Professor & Director Cardiothoracic Radiology Associate Chair for Clinical Affairs University of Michigan NLST STOPPED! Lung cancer trial results
More informationLung Cancer Screening
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Lung Cancer Screening Version 1.2013 NCCN.org Continue Version 1.2013, 06/15/12 National Comprehensive Cancer Network, Inc. 2012, All rights
More informationClinical Policy Title: Lung cancer screening
Clinical Policy Title: Lung cancer screening Clinical Policy Number: 07.01.02 Effective Date: July 1, 2016 Initial Review Date: April 27, 2016 Most Recent Review Date: March 6, 2018 Next Review Date: March
More informationFaculty Disclosure. Objectives. Lung Cancer in Kentucky: Improving Patient Outcomes 10/28/16. Lung Cancer Burden in Kentucky
Lung Cancer in Kentucky: Improving Patient Outcomes Faculty Disclosure The presenter and members of the development team do not have any conflicts to report. Celeste T. Worth, MCHES Kentucky Collaborative
More informationPANEL DISCUSSION: SCREENING FOR LUNG CANCER. Anthony D Weaver MD
PANEL DISCUSSION: SCREENING FOR LUNG CANCER Anthony D Weaver MD Disclosures Anthony Weaver has no relationships to disclose. Thank God! A panel of experts! An Equal Opportunity University Objectives 1.
More informationPage 1. Selected Controversies. Cancer Screening! Selected Controversies. Breast Cancer Screening. ! Using Best Evidence to Guide Practice!
Cancer Screening!! Using Best Evidence to Guide Practice! Judith M.E. Walsh, MD, MPH! Division of General Internal Medicine! Womenʼs Health Center of Excellence University of California, San Francisco!
More informationLung Cancer Screening: Radiologic and Clinical Implications. Katherine R. Birchard, M.D. University of North Carolina at Chapel Hill
Lung Cancer Screening: Radiologic and Clinical Implications Katherine R. Birchard, M.D. University of North Carolina at Chapel Hill Nothing to disclose Objectives In context of NLST: Review Imaging Techniques
More informationSelected Controversies. Cancer Screening. Breast Cancer Screening. Selected Controversies. Page 1. Using Best Evidence to Guide Practice
Cancer Screening Using Best Evidence to Guide Practice Judith M.E. Walsh, MD, MH Division of General Internal Medicine Women s Health Center of Excellence University of California, San Francisco Selected
More informationLung Cancer Screening, Version
412 NCCN Lung Cancer Screening, Version 3.2018 Clinical Practice Guidelines in Oncology Douglas E. Wood, MD; Ella A. Kazerooni, MD; Scott L. Baum, MD; George A. Eapen, MD; David S. Ettinger, MD; Lifang
More informationSHARED DECISION MAKING AND LUNG CANCER SCREENING
SHARED DECISION MAKING AND LUNG CANCER SCREENING DISCLOSURES Cathleen E. Morrow, MD None William C. Black, MD No financial disclosure Co-investigator for NLST Member of the ACR Lung-RADS Screening Registry
More information2018 Community Outreach Report
4.1 Prevention Program Lung Cancer Prevention 2018 Community Outreach Report The focus on prevention of lung cancer was chosen by the Cancer Committee because lung cancer is the leading cause of death
More informationNon-Small Cell Lung Cancer Causes, Risk Factors, and Prevention
Non-Small Cell Lung Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for
More informationSmall Cell Lung Cancer Causes, Risk Factors, and Prevention
Small Cell Lung Cancer Causes, Risk Factors, and Prevention Risk Factors A risk factor is anything that affects your chance of getting a disease such as cancer. Learn more about the risk factors for small
More informationLung Cancer Screening in the Midwest of the US: When Histoplasmosis Complicates the Picture
Cronicon OPEN ACCESS EC PULMONOLOGY AND RESPIRATORY MEDICINE Case Report Lung Cancer Screening in the Midwest of the US: When Histoplasmosis Complicates the Picture Swan Lee 1 and Rolando Sanchez Sanchez
More informationSCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art
SCBT-MR 2016 Lung Cancer Screening in Practice: State of the Art Reginald F. Munden MD, DMD, MBA I have no conflicts of interest to report National Lung Cancer Screening Trial 20% lung cancer mortality
More informationRobert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center
You Smoke, You Get Lung Cancer, You Die: Can Screening Change this Paradigm? Robert J. McKenna M.D. Chief, Thoracic Surgery Cedars Sinai Medical Center AATS Saturday 4/28/2012 Cancer Screening Cancer
More informationEarly Detection of Lung Cancer. Amsterdam March 5 th 2010
Early Detection of Lung Cancer Amsterdam March 5 th 2010 Rob J van Klaveren, MD, PhD Dept. of Pulmonology Erasmus MC Rotterdam, the Netherlands Early Detection and Screening - Questions to be addressed
More informationScreening for Lung Cancer: Are We There Yet?
Screening for Lung Cancer: Are We There Yet? Kavita Garg, MD Professor of Radiology University of CO, Denver Mountain States Cancer Conference Nov 6 th 2010 The Epidemiology of Lung Cancer Tobacco is the
More informationOutline. The Lung Cancer Patient in 2011 Not the Marlboro Man. Lung Cancer
Outline The Lung Cancer Patient in 2011 Not the Marlboro Man Jeanne Griffin Vaughn, APN-BC, AOCN Epidemiology Staging and Patterns of Spread Clinical Presentation Treatments March 26, 2011 Lung Cancer
More informationProtocol: Screening for Lung Cancer
Protocol: Screening for Lung Cancer May 2014 ERSC Project Lead Investigator: Donna Fitzpatrick-Lewis CTFPHC Working Group Chair: Gabriela Lewin CTFPHC Working Group Members: Maria Bacchus, Neil Bell, Jim
More informationScreening for Lung Cancer. Michael S. Nolledo, MD Deborah Heart and Lung Center
Screening for Lung Cancer Michael S. Nolledo, MD Deborah Heart and Lung Center 1 1 Outline Ø Introduction Ø Lung Cancer Screening pre-2010 Ø Lung Cancer Screening today 2 2 Lung Cancer 2011 (Siegel et
More informationLung Cancer Screening. Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017
Lung Cancer Screening Ashish Maskey MD Interventional Pulmonology UK Health Care Dec 1 st 2017 Nearly one in six American adults currently smoke cigarettes An estimated 40 million adults in the United
More informationLung cancer forms in tissues of the lung, usually in the cells lining air passages.
Scan for mobile link. Lung Cancer Lung cancer usually forms in the tissue cells lining the air passages within the lungs. The two main types are small-cell lung cancer (usually found in cigarette smokers)
More informationLung Cancer. Background and Developments Regarding the Role of Asbestos as a Cause of Lung Cancer and New Lung Cancer Claims
Lung Cancer Background and Developments Regarding the Role of Asbestos as a Cause of Lung Cancer and New Lung Cancer Claims Smoking Smoking Smoking as a Cause Approximately 90% of all Lung Cancers are
More informationVHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening
VHA Demonstration Project for Lung Cancer Screening Using Low-Dose Chest CT Screening ATS San Francisco 2016 James K. Brown MD 1, Kathryn L. Rice, MD 2 (1) San Francisco VA (2) Minneapolis VAMC Disclosures
More informationLung cancer screening in Switzerland
SAMO Interdisciplinary Workshop on Chest Tumors 27 th and 28 th January 2017 Hotel Hermitage, Lucerne Lung cancer screening in Switzerland Walter Weder, MD, Professor of Surgery University Hospital Zurich,
More information5/12/2016. a seasoned clinician s perspective
a seasoned clinician s perspective Thomas J Gross, MD Professor of Internal Medicine Pulmonary, Critical Care, & Occupational Medicine Carver College of Medicine Street cred: Medical Director Pulmonary
More informationFrequently Asked Questions for Clinicians For screening of lung cancer in high-risk patients
Frequently Asked Questions for Clinicians For screening of lung cancer in high-risk patients What is EarlyCDT Lung? EarlyCDT Lung is a simple, affordable blood test for the early detection of lung cancer.
More informationAnn Intern Med. 2012;156(5):
Lung Cancer Screening Update Doug Arenberg, M.D. University of Michigan Outline Screening; Some simple but necessary truths Do people benefit from screening? What are the harms (and are they outweighed
More informationLung Cancer Update. Disclosures. None
Lung Cancer Update Ronald J Servi DO FCCP Adjunct Assistant Professor Department of Pulmonary Medicine University of Texas MD Anderson Cancer Center Banner MD Anderson Cancer Center Gilbert, Arizona Disclosures
More informationWill CT screening reduce overall lung cancer mortality? Associate Professor of Radiology Department of Medical Imaging UHN / MSH / WCH
Will CT screening reduce overall lung cancer mortality? Heidi Roberts MD FRCP(C) Heidi Roberts, MD, FRCP(C) Associate Professor of Radiology Department of Medical Imaging UHN / MSH / WCH Screening - Requirements
More informationCurrent Approach to Screening for Lung Cancer. James R Jett M.D.
Current Approach to Screening for Lung Cancer James R Jett M.D. Potential Conflicts of Interest I am Chief Medical Officer for Oncimmune Ltd (Biomarkers of Cancer) Co-Editor of Lung Cancer Section of UP-TO-DATE
More informationLDCT Screening. Steven Kirtland, MD. Virginia Mason Medical Center February 27, 2015
LDCT Screening Steven Kirtland, MD Virginia Mason Medical Center February 27, 2015 2 Disclosures 4 5 Cancer Screening Mrs H 64yo 50 pk year smoker Lung Cancer Epidemiology Leading Cause of Cancer Death
More information10/17/16. Lung Cancer Screening. Question 1: Does lung cancer screening make sense? 3rd lung cancer third most prevalent tumor type
Lung Cancer Screening Greg Rogalski Mercy Radiology Group greg@grogo.org Question 1: Does lung cancer screening make sense? 2 Requirements for successful screening process Sufficiently high prevalence
More informationIEHP UM Subcommittee Approved Authorization Guidelines CT Screening (Low Dose) for Lung Cancer
CT Screening (Low Dose) for Lung Cancer Policy: There is currently adequate evidence that using low dose computed tomography (LDCT) to screen asymptomatic individuals who are at risk for lung cancer improves
More informationSlide 1. Slide 2. Slide 3. Investigation and management of lung cancer Robert Rintoul. Epidemiology. Risk factors/aetiology
Slide 1 Investigation and management of lung cancer Robert Rintoul Department of Thoracic Oncology Papworth Hospital Slide 2 Epidemiology Second most common cancer in the UK (after breast). 38 000 new
More informationOpen Access Review Article DOI: /cureus.589. Joshua Dajac 1, Jay Kamdar 1, Austin Moats 2, Brenda Nguyen 1
Open Access Review Article DOI: 10.7759/cureus.589 To Screen or not to Screen: Low Dose Computed Tomography in Comparison to Chest Radiography or Usual Care in Reducing Morbidity and Mortality from Lung
More informationLung Cancer Screening:
Lung Cancer Screening: Maximizing Gain and Dealing with Pandora s Box Mark M. Fuster, MD Division of Pulmonary & Critical Care UCSD Department of Medicine & VA San Diego Healthcare Service San Diego, CA
More informationFormer Worker Medical Screening Program Development of Low Dose CT Scan Screening Project
Former Worker Medical Screening Program Development of Low Dose CT Scan Screening Project Nicole Richardson UI College of Public Health Dr. Laurence Fuortes Outline Background of the Former Worker Medical
More informationSubject: Low-Dose Helical (Spiral) Computed Tomography for Lung Cancer Screening Guidance Number: MCG-137 Revision Date(s): 5/13/2015
Subject: Low-Dose Helical (Spiral) Computed Tomography for Lung Cancer Screening Guidance Number: MCG-137 Revision Date(s): 5/13/2015 Original Effective Date: 6/26/2013 DESCRIPTION OF PROCEDURE/SERVICE/PHARMACEUTICAL
More informationAn Update on Lung Cancer Screening Policy and the Role of Quitlines
An Update on Lung Cancer Screening Policy and the Role of Quitlines Robert J. Volk, PhD Vance Rabius, PhD The University of Texas MD Anderson Cancer Center North American Quitline Consortium NAQC Conference
More informationLung Cancer Screening: Evidence and current recommendations
Lung Cancer Screening: Evidence and current recommendations 20 th March 2018 Dr Annette McWilliams Fiona Stanley Hospital University of Western Australia WA Cancer & Palliative Care Network I have no financial
More informationThoracic and head/neck oncology new developments
Thoracic and head/neck oncology new developments Goh Boon Cher Department of Hematology-Oncology National University Cancer Institute of Singapore Research Clinical Care Education Scope Lung cancer Screening
More information